Bellevue Life Sciences Acquisition Corp. (BLAC) Earning

$11.40

south_east
-$0.09 (-0.78%)
Day's range
$11.32
Day's range
$11.6

Bellevue Life Sciences Acquisition Corp. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/14/2024 Q3 2024 -$0.06 $0
08/19/2024 Q2 2024 -$0.02 $0
05/15/2024 Q1 2024 -$0.01 $0
04/17/2024 Q4 2023 -$0.01 $0
11/07/2023 Q3 2023 $0.01 $0
08/14/2023 Q2 2023 $0.03 $0
05/22/2023 Q1 2023 $0.02 $0
03/31/2023 Q4 2022 -$0.00 $0
09/29/2022 Q3 2022 -$0.00 $0
06/29/2022 Q2 2022 -$0.00 $0
03/30/2022 Q1 2022 $0.00 $0
12/30/2021 Q4 2021 $0.00 $0
09/29/2021 Q3 2021 $0.00 $0
06/29/2021 Q2 2021 -$0.00 $0
03/30/2021 Q1 2021 $0.00 $0
 

Bellevue Life Sciences Acquisition Corp. Earnings: FAQ's

How can I listen to Bellevue Life Sciences Acquisition Corp.'s earnings conference call?

The conference call for Bellevue Life Sciences Acquisition Corp.'s latest earnings report can be listened to online.

How can I read Bellevue Life Sciences Acquisition Corp.'s conference call transcript?

The conference call transcript for Bellevue Life Sciences Acquisition Corp.'s latest earnings report can be read online.

How much profit does Bellevue Life Sciences Acquisition Corp. generate each year?

Bellevue Life Sciences Acquisition Corp. (:BLAC) has a recorded net income of $0. Bellevue Life Sciences Acquisition Corp. has generated $0.0718 earnings per share over the last four quarters.

What is Bellevue Life Sciences Acquisition Corp.'s price-to-earnings ratio?

Bellevue Life Sciences Acquisition Corp. (:BLAC) has a price-to-earnings ratio of -96.59 and price/earnings-to-growth ratio is 0.55.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED